{
  "guid": "http://files.libertyfund.org/econtalk/y2020/Prasadmalignant.mp3",
  "title": "Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant",
  "description": "<p>Oncologist, author, and podcaster Vinay Prasad talks about his book Malignant with EconTalk host Russ Roberts. Prasad lays out the conflicts of interest and scientific challenges that make drugs that fight cancer so disappointing at times. The conversation looks at how policy changes might improve the incentives facing doctors, pharmaceutical companies, and patients.</p>\n",
  "pubDate": "Mon, 20 Apr 2020 06:30:00 +0000",
  "author": "webmaster@econlib.org (Library of Economics and Liberty)",
  "link": "https://www.econtalk.org/vinay-prasad-on-cancer-drugs-medical-ethics-and-malignant/",
  "content:encoded": "<p>Oncologist, author, and podcaster Vinay Prasad talks about his book Malignant with EconTalk host Russ Roberts. Prasad lays out the conflicts of interest and scientific challenges that make drugs that fight cancer so disappointing at times. The conversation looks at how policy changes might improve the incentives facing doctors, pharmaceutical companies, and patients.</p>\n",
  "enclosure": "",
  "itunes:title": "Vinay Prasad on Cancer Drugs, Medical Ethics, and Malignant",
  "itunes:author": "Library of Economics and Liberty",
  "itunes:duration": "01:18:04",
  "itunes:summary": "Oncologist, author, and podcaster Vinay Prasad talks about his book Malignant with EconTalk host Russ Roberts. Prasad lays out the conflicts of interest and scientific challenges that make drugs that fight cancer so disappointing at times. The conversation looks at how policy changes might improve the incentives facing doctors, pharmaceutical companies, and patients.",
  "itunes:subtitle": "Oncologist, author, and podcaster Vinay Prasad talks about his book Malignant with EconTalk host Russ Roberts. Prasad lays out the conflicts of interest and scientific challenges that make drugs that fight cancer so disappointing at times. The conversation looks at how policy changes might improve the incentives facing doctors, pharmaceutical companies, and patients.",
  "itunes:keywords": "economics, pharmaceuticals, vinay prasad, econlib, incentives, healthcare, medicines",
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "itunes:episode": 732
}